Navigation Links
Halozyme Therapeutics Presents Favorable New Safety and Pharmacokinetic Data on rHuPH20 Enzyme Produced Via New Manufacturing Process at European Federation for Pharmaceutical Sciences
Date:3/10/2008

00 U/kg (30 mg/kg) were well-tolerated following either IV or SC

dosing.

-- Daily administration of rHuPH20 for one week was well tolerated via

either IV or SC delivery at a daily bolus dose of 600,000 U/kg

(5 mg/kg). No test article-related changes were observed in any

toxicology parameters and no systemic enzyme accumulation was observed.

-- A 3-month interim analysis from an ongoing 39-week chronic toxicity

study with weekly dosing up to 240,000 U/kg revealed no changes in

standard toxicity parameters or in male fertility assessment.

"These studies further expand the safety database for rHuPH20 in both dose and duration, and support the potential use of rHuPH20 from Halozyme's new manufacturing process in chronic applications," said Walter Bee, PhD, Halozyme's Vice President of Preclinical Development. "We anticipate that this toxicology package will be supportive of our current and future Enhanze(TM) Technology partners' regulatory applications."

About Enhanze Technology

Enhanze Technology is Halozyme's proprietary drug delivery technology based on recombinant human hyaluronidase (rHuPH20), a recombinant form of the naturally occurring human enzyme being investigated for its ability to break down hyaluronic acid (HA), the space-filling "gel"-like substance that is a major component of tissues throughout the body. When combined or co-formulated with certain injectable drugs, Enhanze(TM) Technology can act as a "molecular machete" to facilitate the penetration and dispersion of these drugs by temporarily opening flow channels under the skin. Molecules as large as 200 nanometers may pass freely through the perforated extracellular matrix, which recovers its normal density within approximately 24 hours, leading to a drug delivery platform which does not permanently alter the architecture of the skin.

About Halozyme Therapeutics, Inc.

Halozyme is a biopharmaceutical
'/>"/>

SOURCE Halozyme Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Halozyme Therapeutics to Hold Pipeline Update Conference Call on March 14
2. Halozyme Therapeutics to Present at the BIO CEO and Investor Conference and the Roth Growth Stock Conference
3. Halozyme Therapeutics Amends Stockholder Rights Plan
4. Halozyme Therapeutics Reports 2007 Third Quarter Financial Results
5. Halozyme Therapeutics to Present at UBS 2007 Global Life Sciences Conference
6. Baxter and Halozyme Announce Collaboration for Development of Subcutaneous GAMMAGARD LIQUID(TM) Administration Using Enhanze(TM) Technology
7. Alseres Pharmaceuticals Presents Inosine and Dopamine Transporter (DAT) Blocker Preclinical Data at the American Society for Experimental NeuroTherapeutics (ASENT) Conference
8. Elusys Therapeutics Appoints Robert Gundel as Vice President of Research
9. Cell Therapeutics, Inc. (CTI) to Present at 7th Annual WBBA Invest Northwest Conference
10. Cell Therapeutics, Inc. (CTI) to Report Fourth Quarter and Year-End Financial Results on March 13
11. ExonHit Therapeutics - 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2014)... , Sept. 1, 2014 Reportlinker.com ... available in its catalogue: India Solid ... http://www.reportlinker.com/p02350445/India-Solid-Waste-Management-Vehicles-Market-Forecast-and-Opportunities-2019.html ... are the main governing bodies responsible for complete ... cities. On an average, around 135,000 MT solid ...
(Date:9/1/2014)... (PRWEB) September 01, 2014 The ... and Diagnostics report provides comprehensive understanding and unprecedented ... entered into by the worlds leading life science ... and analysis of how and why companies enter ... a prospective partner’s negotiated deals terms provides critical ...
(Date:8/31/2014)... September 01, 2014 Available spectra ... needs for research and cultivation of a wide ... Valoya’s proprietary LEDs with proven patented and pending ... uncompromised light uniformity in critical applications in contrast ... LEDs. , “Our customers have a large variety ...
(Date:8/31/2014)... This is a professional and ... Epoxy Hardener industry in Global and China. ... industry, including definitions, applications and industry chain structure. ... are provided with a focus on history, developments, ... comparison between the international and Chinese situation is ...
Breaking Biology Technology:India Solid Waste Management Vehicles Market Forecast and Opportunities, 2019 2India Solid Waste Management Vehicles Market Forecast and Opportunities, 2019 3India Solid Waste Management Vehicles Market Forecast and Opportunities, 2019 4India Solid Waste Management Vehicles Market Forecast and Opportunities, 2019 5India Solid Waste Management Vehicles Market Forecast and Opportunities, 2019 6India Solid Waste Management Vehicles Market Forecast and Opportunities, 2019 7India Solid Waste Management Vehicles Market Forecast and Opportunities, 2019 8Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics Industry Analysis, Size, Share, Growth, Trends And Forecast Research Report by Researchmoz.us 2Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics Industry Analysis, Size, Share, Growth, Trends And Forecast Research Report by Researchmoz.us 3Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics Industry Analysis, Size, Share, Growth, Trends And Forecast Research Report by Researchmoz.us 4Epoxy Hardener Industry Development Trends in Global & China Regions Now Available at ReportsnReports.com 2Epoxy Hardener Industry Development Trends in Global & China Regions Now Available at ReportsnReports.com 3
... 192% from third quarter 2007, - New business awards of $212 ... $1 billion at Sept. 30, 2008, up 16% ... from Dec. 31, 2007, ... research organization, today reported,record net income of $11.0 million or $0.73 per diluted ...
... 67% from Same Prior Year Period, DUBLIN, Calif., ... pharmaceutical company dedicated to the discovery and,development of novel ... and nine months ended September 30, 2008., Total ... compared,with $6.1 million for the same prior year period. ...
... Presentation Scheduled for November 11, 2008 at 9:55 a.m. EST, ... FHC ) today announced that O.B. Parrish, the Company,s Chief,Executive ... Rodman & Renshaw 10th Annual Global Investment Conference at 9:55,a.m. ... held at the,New York Palace Hotel in New York City., ...
Cached Biology Technology:Kendle Reports Record 3Q 08 Net Income and Total Business Authorizations 2Kendle Reports Record 3Q 08 Net Income and Total Business Authorizations 3Kendle Reports Record 3Q 08 Net Income and Total Business Authorizations 4Kendle Reports Record 3Q 08 Net Income and Total Business Authorizations 5Kendle Reports Record 3Q 08 Net Income and Total Business Authorizations 6Kendle Reports Record 3Q 08 Net Income and Total Business Authorizations 7Kendle Reports Record 3Q 08 Net Income and Total Business Authorizations 8SuperGen Reports 2008 Third Quarter Financial Results 2SuperGen Reports 2008 Third Quarter Financial Results 3SuperGen Reports 2008 Third Quarter Financial Results 4SuperGen Reports 2008 Third Quarter Financial Results 5SuperGen Reports 2008 Third Quarter Financial Results 6SuperGen Reports 2008 Third Quarter Financial Results 7SuperGen Reports 2008 Third Quarter Financial Results 8SuperGen Reports 2008 Third Quarter Financial Results 9SuperGen Reports 2008 Third Quarter Financial Results 10The Female Health Company to Present at Rodman & Renshaw 10th Annual Global Investment Conference 2The Female Health Company to Present at Rodman & Renshaw 10th Annual Global Investment Conference 3
(Date:9/2/2014)... history of scientific research on mountain ecosystems, looks ... and sets an agenda for biodiversity conservation throughout ... gloom and mountain glory revisited: A survey of ... appears online in the Journal of Mountain ... Tufts University, Jodi A. Hilty of the Wildlife ...
(Date:9/2/2014)... 2014 In a new study that could ultimately ... campus of The Scripps Research Institute (TSRI) have adapted ... manufacturing sites for molecules that can treat a form ... a reaction vessel and a disease-causing defect as a ... said TSRI Professor Matthew Disney.,"Because the treatment is synthesized ...
(Date:9/2/2014)... by researchers at the University of Warwick in the ... published in the Journal Early Human Development , ... in hospital after birth and the use of mechanical ... preterm children. , Mathematic abilities are crucial for lifelong ... very preterm children. Earlier studies of children who are ...
Breaking Biology News(10 mins):An uphill climb for mountain species? 2An uphill climb for mountain species? 3Scripps Florida scientists make diseased cells synthesize their own drug 2Mechanical ventilation a key indicator for pre-term children's math problems 2
... leading to heart attacks and strokes are treated quite ... lung, but now turn out to involve some of ... in turn provides clues to more effective therapies for ... these distinct fields to come together. The seeds were ...
... are exposed to hairspray in the workplace during pregnancy have ... the genital birth defect hypospadias, according to a new study ... The study is the first to show a ... common birth defects of the male genitalia, where the urinary ...
... becoming increasingly aware of toxic chemical exposure from everyday ... and lead in some toys, women do not readily ... related adverse health effects, according to research from the ... Social Behavior . "People more readily equate ...
Cached Biology News:Mechanisms of cardiovascular disease and cancer give clues to new therapies 2Mechanisms of cardiovascular disease and cancer give clues to new therapies 3Hairspray is linked to common genital birth defect, says study 2Pollution at home lurks unrecognized, instead attributed to large-scale environmental disasters 2
Use our experts and resources to develop reagent systems for your applications....
Request Info...
Ultra-sensitive, non-radioactive detection of Protein G. Measure Protein G levels quickly and easily....
IC50: 190 pg/ml · Limit of detection: 60 pg/ml...
Biology Products: